RecruitingNCT02432092

Pediatric Cardiomyopathy Mutation Analysis


Sponsor

Indiana University

Enrollment

300 participants

Start Date

Apr 1, 2014

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abnormal cardiac function.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is analyzing genetic mutations in children with cardiomyopathy — a disease that weakens or thickens the heart muscle — and their family members, to better understand the inherited causes of the condition and potentially improve diagnosis and treatment. **You may be eligible if...** - You are a child or young person diagnosed with cardiomyopathy (a weakened or abnormally thickened heart muscle) - OR you are a family member of someone diagnosed with cardiomyopathy **You may NOT be eligible if...** - You do not have cardiomyopathy and are not a family member of someone with cardiomyopathy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

IU School of Medicine

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02432092


Related Trials